Kilitch Drugs (India) Ltd.
NSE: KILITCH | BSE: 524500
₹178.15
₹-4.04
(-2.22%)
As on 20-Jul-2026IST
Market cap
₹619 Cr
Revenue (TTM)
₹235 Cr
P/E Ratio
20.5
P/B Ratio
2.2
Div. Yield
0 %
Quality Score
5/10
Growth Score
7/10
Valuation Score
5/10
Momentum Score
3/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹30 Cr
-
ROE
13.2 %
-
ROCE
17.3 %
-
Industry P/E
38.35
-
EV/EBITDA
14.4
-
Debt to Equity
0.2
-
Book Value
₹80
-
EPS
₹13.3
-
Face value
10
-
Shares outstanding
34,961,564
10 Years Aggregate
CFO
₹94.56 Cr
EBITDA
₹96.02 Cr
Net Profit
₹46.52 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kilitch Drugs
| 1.7 | -4.1 | 31.9 | -19.2 | 25.0 | 16.5 | 26.8 |
|
BSE Healthcare
| 15.9 | 5.2 | 15.8 | 11.6 | 23.9 | 13.8 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Kilitch Drugs
| 9.5 | -11.4 | 137.3 | -37.6 | 146.7 | -24.0 | -21.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kilitch Drugs
|
178.2 | 619.2 | 235.5 | 29.5 | 14.0 | 11.1 | 20.5 | 2.2 |
| 8,054.5 | 20,159.0 | 2,275.6 | 187.5 | 10.3 | 22.9 | 107.5 | 23.1 | |
| 2,649.2 | 20,126.0 | 2,187.2 | 649.7 | 31.5 | 19 | 31.4 | 5.6 | |
| 2,046.1 | 12,491.0 | 1,403.2 | 185.1 | -- | 27.4 | 67.5 | 16.7 | |
| 1,463.3 | 20,287.9 | 3,129.4 | 647.4 | 26.9 | 18.1 | 32.7 | 5.2 | |
| 2,408.9 | 38,730.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 54.6 | 9.3 | |
| 4,577.9 | 20,924.3 | 2,519.7 | 722.4 | 33.6 | 17.2 | 29 | 5.0 | |
| 6,852.5 | 11,367.1 | 1,408.0 | 326.9 | 30.8 | 57.1 | 34.8 | 21.7 | |
| 625.5 | 12,235.6 | 1,538.1 | 226.2 | 20.4 | 9 | 50.3 | 4.7 | |
| 1,059.5 | 9,751.4 | 4,858.7 | 574.1 | 14.9 | 19.7 | 17.5 | 3.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Kilitch Drugs
Kilitch Drugs (India) Limited engages in the development and operation of the pharmaceutical business in India and internationally. The company offers various parenteral, nasal, and topical products, such as liquid ampoules, vials, dry powder... injectables, and metered nasal drops for gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, anticoagulant, narcotic, oncology, ophthalmic, antifungal, corticosteroid, anticoagulant, and other applications, as well as vaccines, veterinary products, iron supplements for anemia, Klavmox, and Onecef. It also provides oral formulations, including tablets, capsules, dry syrup, and oral powder for antibiotic, anti-diabetic, cardiovascular, and other areas; effervescent tablets and powders, such as Roipar, Duregra, and Roivit; and nutritional products, including Celtine. In addition, the company offers cosmetics, which include oil, lotion, liquid to cream, paste in skin, and personal and hair care products; herbal products for use in sore throat and prostate problems, as well as a supplement for diabetes, obesity, libido, and other conditions; ortho rehabilitation and implants; and medical devices comprising C-Seal, a skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Further, it provides PH-7 which reduces acid content of the stomach; SRO kit for treating childhood diarrhea; 9-VIT for use in surgery, extensive burns, fractures, and other trauma; and HPURE for sore throat and cough. The company exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India. Read more
-
Incorporated
1992
-
Chairman
--
-
Managing Director
Mukund P Mehta
-
Headquarters
Navi Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Kilitch Drugs
What is the current share price of Kilitch Drugs (India) Ltd Today?
The share price of Kilitch Drugs (India) Ltd is ₹178.15 (NSE) and ₹177.10 (BSE) as of 20-Jul-2026 IST. Kilitch Drugs (India) Ltd has given a return of 25% in the last 3 years.
What is the current PB & PE ratio of Kilitch Drugs (India) Ltd?
The P/E ratio of Kilitch Drugs (India) Ltd is 20.53 times as on 20-Jul-2026, a 46 discount to its peers’ median range of 38.35 times.
The P/B ratio of Kilitch Drugs (India) Ltd is 2.21 times as on 20-Jul-2026, a 57 discount to its peers’ median range of 5.15 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.31
|
2.88
|
|
2024
|
42.02
|
3.56
|
|
2023
|
20.81
|
1.49
|
|
2022
|
35.47
|
1.92
|
|
2021
|
34.21
|
0.99
|
What is the 52 Week High and Low of Kilitch Drugs (India) Ltd?
The 52-week high and low of Kilitch Drugs (India) Ltd are Rs 227.23 and Rs 117.25 as of 20-Jul-2026.
What is the market cap of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd has a market capitalisation of ₹ 619 Cr as on 20-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Kilitch Drugs (India) Ltd?
Before investing in Kilitch Drugs (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.